SCHEMBL9733266

SCHEMBL9733266

CSc1ccc(C(=O)C(C)CC(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.47
MMP13 P45452 1/20 0.47
PLK1 P53350 1/20 0.44
HAO1 Q9UJM8 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
FPR2 P25090 1/20 0.39
AKR1C3 P42330 5/20 0.38
AKR1C2 P52895 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10353455 0.87 HDAC3 (0.49) MMP12HDAC3HDAC4HDAC1HDAC7
SCHEMBL7884174 0.82 TAS1R3 (0.49) PLK1HAO1TAS1R3TAS1R1HDAC3
SCHEMBL9735344 0.82 PLK1 (0.45) PLK1HAO1TAS1R3TAS1R1FPR2
SCHEMBL7325551 0.80 LMNA (0.53) MMP12HDAC3HDAC4HDAC1HDAC7
SCHEMBL8775491 0.80 CHRM2 (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8823315 0.80 PGR (0.52) MMP12MMP2MMP9MMP14MMP15
SCHEMBL135357 0.80 PGR (0.52) MMP12MMP2MMP9MMP14MMP15
SCHEMBL7492485 0.79 TAS1R3 (0.58) MMP12MMP13PLK1HAO1TAS1R3
SCHEMBL8381806 0.79 MAPT (0.44) MMP12HDAC3HDAC4HDAC1HDAC7
SCHEMBL2555527 0.79 MMP2 (0.48) MMP12HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
US-4816454-A CARDIOVASCULAR DISORDERS CASSELLA AKTIENGESELLSCHAFT (DE) 1989-03-28 US disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0156233-A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions MERCK & CO. INC. (US) 1985-10-02 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed